13F filing recap · Q2 2014
What did Fairfax Financial Holdings buy in Q2 2014?
Reported stock-position changes between this filing and the previous one.
Stock value
$1.45B
Positions
41
Estimated turnover
0.3%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
IDIXIdenix Pharmaceuticals Inc$1.21Mreported value+50.4K sharesQCORQuestcor Pharmaceuticals, Inc.$600.0Kreported value+6.5K sharesSUSSSusser Holdings Corporation$517.0Kreported value+6.4K sharesNAVINavient Corp$266.0Kreported value+15.0K sharesNTPIFNam Tai Property Inc.$264.0Kreported value+35.0K shares